As per attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vipul Organics reported FY25 standalone revenue of Rs. 162.80 crore, up 8.5% from Rs. 150.08 crore in FY24. Standalone profit after tax rose to Rs. 4.27 crore from Rs. 3.58 crore (~19% growth), while consolidated PAT jumped ~32.5% to Rs. 4.43 crore from Rs. 3.34 crore. Q4 FY25 was mixed, with revenue rising ~10% YoY to Rs. 44.09 crore but standalone PAT declining ~29% to Rs. 0.75 crore. The board recommended a dividend of Re. 0.80 per share (8%) subject to shareholder approval. The statutory auditor issued an unmodified (clean) opinion on both standalone and consolidated results. The company also appointed M/s. T. F. Khatri and Associates as Secretarial Auditor for FY26 and completed a Rights Issue of ~42.37 lakh shares at Rs. 48 per share on April 8, 2025.
Clean auditor opinion and decent full-year PAT growth (especially on a consolidated basis) are positives, but the weak Q4 PAT and rising debt levels (short-term borrowings up sharply) may temper sentiment. The small 8% dividend and recent equity dilution via rights issue limit near-term shareholder returns.